DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20171556

A study on relationship between severity of diabetic retinopathy and subclinical hypothyroidism

Mitali Borooah, Shobhana Phukan

Abstract


Background: Subclinical hypothyroidism (SCH) is defined as an asymptomatic condition characterized by normal serum levels of free thyroxine and elevated serum concentration of thyrotropin (>4.0µIU/ml). Association between diabetic retinopathy and SCH is unclear. Aim was to study the relationship between severity of diabetic retinopathy and SCH in patients of diabetic retinopathy with type 2 diabetes mellitus.

Methods: 120 patients of diabetic retinopathy with known type 2 diabetes mellitus were taken and categorized them according to severity of diabetic retinopathy as per ETDRS classification. Serum thyrotropin (TSH) and free thyroxine (FT4) concentration were measured in all 120 patients. Patients with normal TSH and FT4 values are euthyroid patients and those with normal FT4 but TSH value >4µIU/ml are considered as having subclinical hypothyroidism. Severity of diabetic retinopathy is compared between the euthyroid and subclinical hypothyroid group.

Results: Out of the 120 patients included in the study, 72 (60%) were male and 48 (40%) were female. 97 patients (80.83%) were Euthyroid and 23 patients (19.17%) had subclinical hypothyroidism. It was observed that prevalence of more severe form of diabetic retinopathy (severe NPDR and PDR) was higher in SCH group as compared to euthyroid group. Severity of diabetic retinopathy was compared with serum TSH level and it was seen that severity of diabetic retinopathy significantly increases with increase in serum TSH value.

Conclusions: Patients with SCH had more severe form of diabetic retinopathy as compared to patients with euthyroidism. Severity of diabetic retinopathy significantly increases with increase in serum TSH value.


Keywords


ETDRS, Free thyroxine, Subclinical hypothyroidism, Thyrotropin

Full Text:

PDF

References


Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. Risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis, Diabetologia. 2001;44(2):156-63.

Chang YC, Wu WC. Dyslipidemia and diabetic retinopathy. Rev Diabet Stud. 2013;10(2-3):121-32.

Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al for the American Association of Clinical Endocrinologists and American Thyroid Association Task force on Hypothyroidism in Adults KA. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid. 2012;22(12):1200-35.

Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabetic Medicine. 1995;12(7):622-7.

Smithson MJ. Screening for thyroid dysfunction in a community population of diabetic patients. Dia Med. 1998;15(2):148-50.

Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34.

Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99.

Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Dia Med. 1995;12(7):622-7.

Kim BY, Kim CH, Jung CH, Mok JO, Suh KI, Kang SK. Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes. Endocrine J. 2011;58(12):1065-70.

Yang GR, Yang JK, Zhang L, An YH, Lu JK. Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study. Tohoku J Exp Med. 2010;222(4):303-10.

Yang JK, Liu W, Shi J, Li YB. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Dia Care. 2010;33(5):1018-20.

Wu J, Yue S, Geng J, Liu L, Teng W, Liu L, et al. Relationship between diabetic retinopathy and subclinical hypothyroidism: a meta-analysis. Scientific Reports. 2015;5:12212.

Khodeir SA, Raouf AE, Farouk YMG, Allam WA. A study on the relationship between subclinical hypothyroidism and diabetic retinopathy in type2 diabetic patients. J Am Sci. 2012;8(1):525-30.

Kim SR, Tull ES, Talbott EO, Vogt MT, Kuller LH. A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis. Medical hypotheses. 2002;59(6):660-6.

Robison Jr WG, Jacot JL, Katz ML. Retinal vascular changes induced by oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther. 2000;16(2):109-20.

Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal. 2005;7(11-12):1581-87.